Trial of IIb Preserving Neck Dissection
Randomized Controlled Trial of IIb Preserving Neck Dissection VS Neck Dissections Involving IIb Removal (Selective/Functional) in Patients With N0 Neck With Oral Cavity Malignancies
1 other identifier
interventional
32
1 country
1
Brief Summary
The treatment of clinically N0 neck in malignancies of oral cavity is controversial. The options include the policy of "wait and watch"(close observation and follow-up), elective irradiation of the neck, elective surgery of the neck (neck dissection). In elective neck dissections, the procedures commonly performed are modified radical neck dissection-III (functional neck dissection) and selective (supraomohyoid) neck dissection depending on the site of the primary lesion within the oral cavity. There are no trials of IIb preserving neck dissection in cancers of the oral cavity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2007
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2007
CompletedFirst Submitted
Initial submission to the registry
February 18, 2009
CompletedFirst Posted
Study publicly available on registry
February 19, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2009
CompletedJuly 17, 2018
July 1, 2018
2 years
February 18, 2009
July 14, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Spinal accessary nerve function
2 years
Secondary Outcomes (1)
neck Node failure
2 years
Study Arms (2)
1
EXPERIMENTALIIb preserving neck dissection
2
OTHERConventional neck dissection
Interventions
Eligibility Criteria
You may qualify if:
- Patients \>18yrs of age.
- histologically proven squamous cell carcinoma
- clinical and radiological N0 neck
You may not qualify if:
- Pregnant and lactating women
- Patients with synchronous primaries
- H/o previous malignancy except BCC
- Previous surgeries on neck
- Post radiotherapy recurrence.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Banaras Hindu University
Varanasi, Uttar Pradesh, 221005, India
Related Publications (6)
Coskun HH, Erisen L, Basut O. Selective neck dissection for clinically N0 neck in laryngeal cancer: is dissection of level IIb necessary? Otolaryngol Head Neck Surg. 2004 Nov;131(5):655-9. doi: 10.1016/j.otohns.2004.04.014.
PMID: 15523444BACKGROUNDRobbins KT, Doweck I, Samant S, Vieira F. Effectiveness of superselective and selective neck dissection for advanced nodal metastases after chemoradiation. Arch Otolaryngol Head Neck Surg. 2005 Nov;131(11):965-9. doi: 10.1001/archotol.131.11.965.
PMID: 16301367BACKGROUNDOrhan KS, Demirel T, Baslo B, Orhan EK, Yucel EA, Guldiken Y, Deger K. Spinal accessory nerve function after neck dissections. J Laryngol Otol. 2007 Jan;121(1):44-8. doi: 10.1017/S0022215106002052. Epub 2006 Jul 3.
PMID: 17040583BACKGROUNDvan Wilgen CP, Dijkstra PU, Nauta JM, Vermey A, Roodenburg JL. Shoulder pain and disability in daily life, following supraomohyoid neck dissection: a pilot study. J Craniomaxillofac Surg. 2003 Jun;31(3):183-6. doi: 10.1016/s1010-5182(03)00030-1.
PMID: 12818606BACKGROUNDTaylor RJ, Chepeha JC, Teknos TN, Bradford CR, Sharma PK, Terrell JE, Hogikyan ND, Wolf GT, Chepeha DB. Development and validation of the neck dissection impairment index: a quality of life measure. Arch Otolaryngol Head Neck Surg. 2002 Jan;128(1):44-9. doi: 10.1001/archotol.128.1.44.
PMID: 11784253BACKGROUNDPandey M, Karthikeyan S, Joshi D, Kumar M, Shukla M. Results of a randomized controlled trial of level IIb preserving neck dissection in clinically node-negative squamous carcinoma of the oral cavity. World J Surg Oncol. 2018 Nov 8;16(1):219. doi: 10.1186/s12957-018-1518-z.
PMID: 30409212DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Manoj Pandey, MS
Banaras Hindu University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Surgical Oncology
Study Record Dates
First Submitted
February 18, 2009
First Posted
February 19, 2009
Study Start
August 1, 2007
Primary Completion
August 1, 2009
Study Completion
August 1, 2009
Last Updated
July 17, 2018
Record last verified: 2018-07